Vericel (VCEL) Gross Profit Growth (3y) (2014 - 2026)
Vericel (VCEL) Gross Profit Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | 54.36% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | 7.16% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | 3.86% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 79.18% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | 51.16% |
| 10 | Vericel | 2.32 Bn | 2.18 Bn | 49.27 Mn | 22.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.93% |
| Dec 31, 2025 | 24.11% |
| Sep 30, 2025 | 25.25% |
| Jun 30, 2025 | 26.82% |
| Mar 31, 2025 | 15.65% |
| Dec 31, 2024 | 19.79% |
| Sep 30, 2024 | 23.53% |
| Jun 30, 2024 | 10.80% |
| Mar 31, 2024 | 15.43% |
| Dec 31, 2023 | 12.97% |
| Sep 30, 2023 | 10.85% |
| Jun 30, 2023 | 38.16% |
| Mar 31, 2023 | 16.54% |
| Dec 31, 2022 | 9.91% |
| Sep 30, 2022 | 6.02% |
| Jun 30, 2022 | 10.09% |
| Mar 31, 2022 | 21.21% |
| Dec 31, 2021 | 14.44% |
| Sep 30, 2021 | 15.49% |
| Jun 30, 2021 | 33.60% |